97 related articles for article (PubMed ID: 38539235)
1. The neoantigens derived from transposable elements - A hidden treasure for cancer immunotherapy.
Hu Z; Guo X; Li Z; Meng Z; Huang S
Biochim Biophys Acta Rev Cancer; 2024 Jun; 1879(5):189126. PubMed ID: 38849060
[TBL] [Abstract][Full Text] [Related]
2. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
[TBL] [Abstract][Full Text] [Related]
3. Gene fusion neoantigens: Emerging targets for cancer immunotherapy.
Wang Y; Shi T; Song X; Liu B; Wei J
Cancer Lett; 2021 May; 506():45-54. PubMed ID: 33675984
[TBL] [Abstract][Full Text] [Related]
4. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract][Full Text] [Related]
5. TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.
Wu J; Zhao W; Zhou B; Su Z; Gu X; Zhou Z; Chen S
Genomics Proteomics Bioinformatics; 2018 Aug; 16(4):276-282. PubMed ID: 30223042
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
8.
Sun Y; Li L; Yao W; Liu X; Yang Y; Ma B; Xue D
Front Genet; 2021; 12():762160. PubMed ID: 34795697
[TBL] [Abstract][Full Text] [Related]
9. Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma.
Lin A; Xu W; Luo P; Zhang J
Front Pharmacol; 2021; 12():721181. PubMed ID: 34721019
[TBL] [Abstract][Full Text] [Related]
10. Alternatively Spliced Isoforms of
Althenayyan S; AlMuhanna MH; AlAbdulrahman A; Alghanem B; Alsagaby SA; Alfahed A; Alasiri G; Aziz MA
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675796
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis Based on TCGA: MUC16 Mutation Correlates with Clinical Outcome in Gastric Cancer.
Huang L; Zheng S; Fu J; Zhang M; Ge X; Mu N
Dis Markers; 2022; 2022():6734105. PubMed ID: 36051359
[TBL] [Abstract][Full Text] [Related]
12. Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.
Palmer CD; Rappaport AR; Davis MJ; Hart MG; Scallan CD; Hong SJ; Gitlin L; Kraemer LD; Kounlavouth S; Yang A; Smith L; Schenk D; Skoberne M; Taquechel K; Marrali M; Jaroslavsky JR; Nganje CN; Maloney E; Zhou R; Navarro-Gomez D; Greene AC; Grotenbreg G; Greer R; Blair W; Cao MD; Chan S; Bae K; Spira AI; Roychowdhury S; Carbone DP; Henick BS; Drake CG; Solomon BJ; Ahn DH; Mahipal A; Maron SB; Johnson B; Rousseau R; Yelensky R; Liao CY; Catenacci DVT; Allen A; Ferguson AR; Jooss K
Nat Med; 2022 Aug; 28(8):1619-1629. PubMed ID: 35970920
[TBL] [Abstract][Full Text] [Related]
13. Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
Simnica D; Kobold S
N Engl J Med; 2022 Aug; 387(6):573. PubMed ID: 35947720
[No Abstract] [Full Text] [Related]
14. The clinical progress of mRNA vaccines and immunotherapies.
Barbier AJ; Jiang AY; Zhang P; Wooster R; Anderson DG
Nat Biotechnol; 2022 Jun; 40(6):840-854. PubMed ID: 35534554
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.
Chandran SS; Ma J; Klatt MG; Dündar F; Bandlamudi C; Razavi P; Wen HY; Weigelt B; Zumbo P; Fu SN; Banks LB; Yi F; Vercher E; Etxeberria I; Bestman WD; Da Cruz Paula A; Aricescu IS; Drilon A; Betel D; Scheinberg DA; Baker BM; Klebanoff CA
Nat Med; 2022 May; 28(5):946-957. PubMed ID: 35484264
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
